| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Us-gaap_othernonoperatingincomeexpense | - | - | - | 1 |
| Total other expense | -64 | -80 | -59 | - |
| Net loss | -7,244 | -1,882 | -1,921 | -1,060 |
| Net loss attributable to noncontrolling interest | -765 | -690 | -766 | -523 |
| Net loss attributable to common shareholders | -6,479 | -1,192 | -1,155 | -537 |
| Loss per share attributable to shareholders basic and diluted (in dollars per share) | -0.02 | -0.004 | -0.004 | -0.002 |
| Weighted average number of common shares outstanding (in shares) | 308,974,027 | 303,196,989 | 301,274,243 | 300,488,824 |
BIOLARGO, INC. (BLGO)
BIOLARGO, INC. (BLGO)